Independent register of U.S. FDA drug recalls · updated Oct 13, 2026
RxRecalls Get alerts

FDA Drug Recalls

14,806 recalls, newest first

Class II · Moderate risk

Sevoflurane

Failed Stability Specifications

Terminated Stability / shelf life Baxter Healthcare Corporation NDC 10019-651-64 D-1435-2019
Class II · Moderate risk

Heparin Sodium 25

Subpotent Drug: low out-of-specification results were identified for the drug anti-factor IIa potency which is intended to ensure that the potency of heparin is within the USP specifications.

Terminated Wrong potency / content B. Braun Medical Inc NDC 0264-9587-20 D-1343-2019

Recalls by year